A culturally and medically tailored meal program reduced hospitalizations among Navajo Nation residents with heart failure, ...

In a global cohort of people from 15 countries, 7% had coronary plaque despite a coronary artery calcium score of 0, ...

The addition of pembrolizumab to neoadjuvant chemotherapy followed by single-agent adjuvant pembrolizumab improved long-term ...

Results showed patients who undergo arthroscopic rotator cuff repair may experience a reduction in pain and narcotic use with ...

Adults with moderate to severe hidradenitis suppurativa experienced substantial long-term symptom relief and quality of life ...

SYD-101 significantly slowed the progression of myopia in younger children and quick progressors over 36 months, according to ...

Litifilimab was superior to placebo for reducing skin disease activity in cutaneous lupus erythematosus, according to phase 2 ...

Once-daily oral zasocitinib for moderate to severe plaque psoriasis demonstrated rapid and durable skin clearance and a ...

In a phase 2 trial, OCU410, a modifier gene therapy for geographic atrophy secondary to dry age-related macular degeneration, ...

In stable patients without heart failure, discontinuing beta-blockers 1 year after a heart attack was noninferior to continued use for all-cause death, recurrent MI or HF hospitalization, researchers ...

Most underage users on social media can see posts promoting celebrity-owned alcohol brands, many of which are not disclosed ...

Smartphone notifications that alerted patients first, rather than their physicians, of early heart failure decompensation were feasible and safe, according to results from the NOTIFY-HF pilot ...